EPO Patents = 1

Forward Citations = 855

Loading Chart...

3 inventors (with patents filed for the assignee):

Malek Faham (9 out of 54 patents)

Thomas Willis (9 out of 30 patents)

Martin Moorhead (2 out of 9 patents)

9 patents: Sort by Forward Citations

1. 9228232 - Methods of monitoring conditions by sequence analysis (2016-01-05),

2. 9217176 - Methods of monitoring conditions by sequence analysis (2015-12-22),

3. 9043160 - Method of determining clonotypes and clonotype profiles (2015-05-26),

4. 8795970 - Methods of monitoring conditions by sequence analysis (2014-08-05),

5. 8748103 - Monitoring health and disease status using clonotype profiles (2014-06-10),

6. 8691510 - Sequence analysis of complex amplicons (2014-04-08),

7. 8628927 - Monitoring health and disease status using clonotype profiles (2014-01-14),

8. 8507205 - Single cell analysis by polymerase cycling assembly (2013-08-13),

9. 8236503 - Methods of monitoring conditions by sequence analysis (2012-08-07),

Company Overview

Sequenta, Inc. is a biotechnology company specializing in immune repertoire profiling. Their innovative technology enables high-throughput sequencing of immune receptors to provide valuable insights for precision medicine and immunotherapy development. With a strong focus on research and development, Sequenta aims to revolutionize personalized medicine by decoding immune system diversity and function.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#110 in South San Francisco, CA

#7,735 in California

#32,588 in US

South San Francisco, CA, United States of America

Sequenta, Inc.

Forward Citations = 855

3 inventors:

Malek Faham (9 out of 54 patents)

Thomas Willis (9 out of 30 patents)

Martin Moorhead (2 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sequenta, Inc.. Retrieved from https://idiyas.com/company/sequenta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]